Device Trial Radar · NCT06573216
Clinical Trial of Wrist Ambulatory Blood Pressure Monitor in Conformance With the EN ISO 81060-2:2018+AMD1:2020
Last checked: Nov 19, 2026Latest source record: Aug 27, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
128
Actual
Start
Apr 24, 2024
Primary completion
Jun 4, 2024
Study completion Jun 4, 2024
Sponsor
- Lead sponsor
- Huawei Device Co., LtdNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 27, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The accuracy and safety of the Wrist Ambulatory Blood Pressure Recorder (Model: LCA-B10) were assessed according to the requirements of EN ISO 81060-2:2018 + AMD1:2020.
Conditions
- Blood Pressure
Interventions
Wrist Ambulatory Blood Pressure MonitorDevice
Comparing blood pressure measured by wrist blood pressure monitor with mercury sphygmomanometer .
Primary outcomes
What the sponsor says the trial is designed to measure.
- Blood pressure mean deviation and standard deviation- evaluation criterion 1Time frame: 30 minutes
- Blood pressure mean deviation and standard deviation- evaluation criterion 2Time frame: 30 minutes
- The mean deviation and standard deviation of blood pressure measurements under ambulatory blood pressure monitoringTime frame: 30 minutes
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Bin Peng
Chenzhou, Hunan, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.